Bauditz Juergen, Lochs Herbert, Ventz Manfred
Medizinische Klinik und Poliklinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Universitätsklinikum Charité, Campus Mitte, Charitéplatz 1, 10117, Berlin.
Med Klin (Munich). 2007 Oct 15;102(10):803-8. doi: 10.1007/s00063-007-1107-3.
Suprasellar germinomas are rare intracranial neoplasms, which mainly occur in children and adolescents and manifest with endocrine symptoms and/or compression syndromes.
The clinical, hormonal and morphological findings as well as treatment and complications were investigated in seven patients (six male, one female) with germinomas.
Mean age at diagnosis was 19.7 years (range 15-32 years). First disease-related symptoms were diabetes insipidus (three patients), loss of libido (two patients), pseudopubertas praecox (one patient), and dwarfism (one patient). However, decisive symptoms leading to final diagnosis were visual disturbances (five patients), pubertas tarda (one patient), and hypogonadism (one patient). All patients were treated by transcranial radiation with a dose of 40-54 Gy. One patient received additional chemotherapy with cisplatin, etoposide, and ifosfamide (PEI). Patients were followed up for 14.6 years (range 7-27 years). Intracranial and pulmonary relapses were observed in two patients. Panhypopituitarism and diabetes insipidus were seen in all patients after treatment. Two patients suffered from loss of vision, two further patients from unilateral amaurosis. One patient developed epilepsy and persistent cognitive impairment. Long-term follow-up shows that two patients died from recurrent disease and decompensated liver cirrhosis, respectively. The other patients are long-term survivors. Full social integration with employment was possible in one case.
Suprasellar germinomas cause endocrine symptoms during early tumor stages, however, diagnosis is generally established when ocular symptoms related to tumor compression are already present. Long-term survival is characterized by panhypopituitarism, diabetes insipidus and, partly, ocular or cerebral defects.
鞍上生殖细胞瘤是罕见的颅内肿瘤,主要发生于儿童和青少年,表现为内分泌症状和/或压迫综合征。
对7例生殖细胞瘤患者(6例男性,1例女性)的临床、激素及形态学表现以及治疗和并发症进行了研究。
诊断时的平均年龄为19.7岁(范围15 - 32岁)。首发与疾病相关症状为尿崩症(3例患者)、性欲减退(2例患者)、性早熟(1例患者)和侏儒症(1例患者)。然而,导致最终诊断的决定性症状是视觉障碍(5例患者)、青春期延迟(1例患者)和性腺功能减退(1例患者)。所有患者均接受了40 - 54 Gy剂量的经颅放疗。1例患者接受了顺铂、依托泊苷和异环磷酰胺(PEI)的辅助化疗。对患者进行了14.6年(范围7 - 27年)的随访。2例患者出现颅内和肺部复发。治疗后所有患者均出现全垂体功能减退和尿崩症。2例患者视力丧失,另外2例患者单眼失明。1例患者发生癫痫和持续性认知障碍。长期随访显示,2例患者分别死于复发性疾病和失代偿性肝硬化。其他患者为长期存活者。其中1例患者实现了完全社会融入并就业。
鞍上生殖细胞瘤在肿瘤早期引起内分泌症状,然而,通常在出现与肿瘤压迫相关的眼部症状时才得以确诊。长期存活的特征为全垂体功能减退、尿崩症,部分患者存在眼部或脑部缺陷。